A detailed history of Cibc World Market Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cibc World Market Inc. holds 155,579 shares of ABT stock, worth $17.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
155,579
Previous 150,579 3.32%
Holding current value
$17.9 Million
Previous $17.1 Million 5.54%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $503,650 - $562,200
5,000 Added 3.32%
155,579 $16.2 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $10.4 Million - $11.5 Million
-94,936 Reduced 38.67%
150,579 $17.1 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $106,424 - $130,272
-1,180 Reduced 0.48%
245,515 $27 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $392,628 - $471,088
-4,110 Reduced 1.64%
246,695 $23.9 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $1.66 Million - $1.85 Million
-16,446 Reduced 6.15%
250,805 $27.3 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $88,917 - $104,661
918 Added 0.34%
267,251 $27.1 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $2.53 Million - $2.97 Million
26,604 Added 11.1%
266,333 $29.2 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $473,253 - $547,938
-4,891 Reduced 2.0%
239,729 $23.2 Million
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $2.28 Million - $2.75 Million
22,313 Added 10.04%
244,620 $26.6 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $661,886 - $807,127
-5,805 Reduced 2.54%
222,307 $26.3 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $8.22 Million - $10.1 Million
71,165 Added 45.34%
228,112 $32.1 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $7.81 Million - $8.64 Million
-66,973 Reduced 29.91%
156,947 $18.5 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $7.88 Million - $9.28 Million
-74,500 Reduced 24.96%
223,920 $26 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $13.3 Million - $15.7 Million
122,380 Added 69.52%
298,420 $35.8 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $1.65 Million - $1.8 Million
15,694 Added 9.79%
176,040 $19.3 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $847,578 - $1.03 Million
9,249 Added 6.12%
160,346 $17.5 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $83,614 - $107,016
1,092 Added 0.73%
151,097 $13.8 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $2.74 Million - $4.01 Million
-43,633 Reduced 22.53%
150,005 $11.8 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $3.4 Million - $3.78 Million
43,256 Added 28.76%
193,638 $16.8 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $1.27 Million - $1.38 Million
-15,498 Reduced 9.34%
150,382 $12.6 Million
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $3.33 Million - $3.89 Million
-45,731 Reduced 21.61%
165,880 $14 Million
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $2.56 Million - $3.09 Million
38,653 Added 22.35%
211,611 $16.9 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $2.31 Million - $2.61 Million
35,205 Added 25.56%
172,958 $12.5 Million
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $4.35 Million - $5.25 Million
-71,558 Reduced 34.19%
137,753 $10.1 Million
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $33.8 Million - $37.3 Million
-586,301 Reduced 73.69%
209,311 $12.8 Million
Q1 2018

May 18, 2018

BUY
$56.27 - $63.62 $38.3 Million - $43.3 Million
680,467 Added 590.97%
795,612 $47.7 Million
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $777,018 - $831,878
-14,475 Reduced 11.17%
115,145 $6.57 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $6.23 Million - $6.95 Million
129,620
129,620 $6.92 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.